Microsphere embolism (ME)-induced up-regulation of
endothelial nitric oxide synthase (eNOS) in endothelial cells of brain microvessels was observed 2-48 h after
ischemia. eNOS induction preceded disruption of the blood-brain barrier (BBB) observed 6-72 h after
ischemia. In vascular endothelial cells, ME-induced eNOS expression was closely associated with
protein tyrosine nitration, which is a marker of generation of
peroxynitrite. Leakage of rabbit
IgG from microvessels was also evident around
protein tyrosine nitration-immunoreactive microvessels. To determine whether eNOS expression and
protein tyrosine nitration in vascular endothelial cells mediates BBB disruption in the ME brain, we tested the effect of a novel
calmodulin-dependent NOS inhibitor, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-
indazole dihydrochloride 3.5 hydrate (DY-9760e), which inhibits eNOS activity and, in turn,
protein tyrosine nitration. Concomitant with inhibition of
protein tyrosine nitration in vascular endothelial cells,
DY-9760e significantly inhibited BBB disruption as assessed by
Evans blue (EB) excretion.
DY-9760e also inhibited cleavage of
poly (ADP-ribose) polymerase as a marker of the apoptotic pathway in vascular endothelial cells. Taken together with previous evidence in which
DY-9760e inhibited
brain edema, ME-induced eNOS expression in vascular endothelial cells likely mediates BBB disruption and, in turn,
brain edema.